TLSA

0.61698.69%
WE

William Edward Tente

Chief Regulatory Officer

Mr. William E. Tente, also known as Bill, M.S. is Chief Regulatory Officer of Tiziana Life Sciences Ltd from 2026. He served as Chief Regulatory Officer at Humacyte, Inc. since March 2018 until September 2022. Mr. Tente joined Legacy Humacyte in 2008 and served in a variety of leadership roles, including as Vice President of Manufacturing and Regulatory Affairs until March 2018. Mr. Tente served as Vice President of Operations of Neurotech USA, Inc., of Neurotech Pharmaceuticals, Inc. from 2002 to 2007. Mr. Tente joined Neurotech USA in July 2002. He has experience in process development, manufacturing and quality operations. Prior to Neurotech, he was the Director of Operations of Chimeric Therapies, Inc. from January 1998 to June 2002 and was responsible for bone marrow transplantation operations. Previously, he was the Director of Clinical Production at CytoTherapeutics, Inc. from 1992 to 1998, where he was responsible for bioprocess development, manufacturing and QC for their encapsulated pain cell therapy product. He has also held positions in bioprocess development and production within the Ares Serono Group, Charles River Biotechnical Services and Schering Biotechnology. He was involved in the development of a number of recombinant biopharmaceuticals and therapeutic monoclonal antibodies including Saizen® (recombinant human growth hormone), Gonal-F® (recombinant human follicle stimulating hormone), Luveris® (recombinant luteinizing hormone) and Ovidrel® (recombinant human chorionic gonadotropin hormone). Mr. Tente was elected to the United States Pharmacopeia (USP) Council of Experts in 1998 and served as the Chairman of its Expert Committee on Gene Therapy, Cell Therapy and Tissue Engineering Products from 2005 to 2010. Mr. Tente holds BS and MS degrees in cell biology and microbiology from the University of Rhode Island and studied at the W. Alton Jones Cell Sciences Center in Lake Placid, NY.

Positions